Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis
Status:
Completed
Trial end date:
2006-02-09
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg
once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent
subjects (12 years of age and older) with vasomotor rhinitis (VMR).